Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
With so many global regulation changes, staying informed is a challenge. Join other regulatory professionals as you navigate the gray together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Either RAC exam (Devices and Drugs) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 21 February 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) has released an updated schedule describing the classification timelines of 26 device classes.
The 17 February release of the schedule is a part of CDRH's 515 Program Initiative, which is part of CDRH's overall Transparency Initiative. The 515 Program is named after Section 515 of the Federal Food, Drug and Cosmetic Act (FD&C Act) which covers the reclassification of medical devices, and seeks to provide transparency in the development of new medical device risk classifications.
As of 2009, 26 medical devices were awaiting final classification. There are currently 22 device classes in various stages of classification development. FDA has collected existing information on all 22 device classes, leaving 15 device classes at a benefit:risk assessment stage, one device class at a proposed rule stage and six device classes at in a post-proposed rule stage awaiting comment.
Tags: Program 515, Reclassification, Classification, Project 515, Transparency Initiative, Latest News, development
Regulatory Focus newsletters
All the biggest regulatory news and happenings.